From an evol-
individuals exposed to ‘ancient? MTBC (figure 6). utionary point of view, the low attack rate in active TB
Taken together, these observations are consistent with suggests that MTBC is not a particularly good pathogen
the notion that ‘modern’ strains have evolved a strategy _ in terms of causing disease, yet, considering the 2 billion
of higher virulence and shorter latency, perhaps to _latently infected individuals, MTBC is extraordinarily
better adapt to the increasing availability of susceptible successful at generating secondary infections once
hosts brought by the large human population increases active TB develops. On a more provocative and highly
of the last few centuries. speculative note, infection with MTBC might in fact
be beneficial to at least some human beings (i.e. individ-
uals who never develop active TB), perhaps because a

8. THE ROLE OF HUMAN GENETIC DIVERSITY low level of constant immune-stimulation might protect
So far our discussion has primarily focused on the against other diseases. It is well known that the BCG
pathogen, maybe because the case for unilateral ‘host- vaccine strain is a potent immune adjuvant which is

specific pathogen adaptation’ might be more plausible used to treat bladder cancer.